Current Perspectives on Gill Health
Infectious and non-infectious gill disorders are well known to cause significant and often far-reaching consequences for salmon farming operations. Branchial pathologies can cause not only direct mortalities but also affect growth performance, the response to other health and welfare challenges, and the ability to successfully manage sea lice. As the economic impact of gill disease becomes better understood, research into both the pathobiology and management of gill disease is also gathering pace.
Join our panel of expert speakers who will share current information on field experience, diagnostics and research of gill diseases in Atlantic salmon aquaculture
June 10, 2022
09:00 – 11:00 UK
10:00 – 12:00 Norway
|Welcome introduction |
Chris Matthews, Business Unit Director of PHARMAQ Analytiq, UK and Ireland
|Gill challenges in North of Norway - Practical implications for fish health management |
Mattias Bendiksen Lind, Havet, Norway
|Gill challenges in the South of Norway - Experience from 2021 season |
Hanna Sæteraas Bjerke, Åkerblå, Norway
|Gill Swabs and Preventive Gill Monitoring |
Angela Ashby, Head of Clinical Services, PHARMAQ Analytiq, UK
|Gill health in Nowegian farmed Atlantic salmon |
Liv Østevik, Veterinary pathologist, PHARMAQ Analytiq, Norway
|Results from field monitoring of gill health in freshwater and seawater - is there a correlation? |
Svein Alexandersen, Senior Manager Commercial Field Vaccines, Therapy and Technical Equipment, PHARMAQ, Norway
|How to move forward and solve the gill challenges |
Renate Johansen, Global Product Manager, PHARMAQ Analytiq, Norway
Mattias Bendiksen Lind
Mattias Bendiksen Lind, fish health biologist, educated at UiT The Arctic University of Norway in 2015. Experience from clinical practice in aqaculture in Northern Norway since 2012. Areas of expertise are disease control and prevention, sealice management, biosafety and general fish health management. He is now working in HaVet Fiskehelse, at the coast of Helgeland.
Hanna Sæteraas Bjerke
Hanna Sæteraas Bjerke, Veterinarian (cand.med.vet) Norwegian University of life Sciences 2016. Experience from clinical practice in Aquaculture in the west parts of Norway. Areas of expertise are disease control, brood fish and lice management. She is now working as Senior consultant in Åkerblå, Region West.
Liv Østevik is a veterinary pathologist at Pharmaq Analytiq. She became a European specialist in anatomic veterinary pathology in 2015, and is currently pursuing a PhD on gill disease of farmed Atlantic salmon. She is also a part of the team that provides diagnostic pathology to the Norwegian aquaculture industry and has a special interest in the use of histopathologic scoring as a tool in research.
Svein Alexandersen, Technical Manager Pharmaq. Has previous been working as researcher in therapeutics and clinical researcher for developing new vaccines and sea lice therapeutics for the aquaculture industry worldwide. Todays focus is the general fish health of Norwegian aquaculture. This is accomplished through a close customer relationship and cooperation with producers, Pharmaq and Pharmaq Analytiq.
Dr Renate Johansen has worked more than 20 years in fish diagnostics & research. Currently she is Fish-health manager in Pharmaq Analytiq, and solving fish health challenges in the industry is her main interest. She has a broad background with research in several areas including a PhD on nodavirus in halibut and post-doc on winter ulcer bacteria in salmon. Gill health problems have changed since she started with fish diagnostics in 1998, but they are still one of the major challenges that we need to solve. In her talk she will summarize the knowledge gaps and possible ways to move forward.
Chris spent five years in terrestrial animal veterinary practice in Scotland and Australia, before completing a Masters degree in aquatic veterinary medicine at the Institute of Aquaculture, University of Stirling. He has practiced as an aquaculture veterinarian for eleven years, seven of those as Operations Director for Fish Vet Group and Business Unit Director (UK & Ireland) for Pharmaq Analytiq following the former’s acquisition by Zoetis in 2020.
Chris is an honorary lecturer at the University of St Andrews’ Scottish Oceans Institute and has consulted and lectured internationally including in developing aquaculture industries.